Suicide gene therapy of chemically induced mammary tumor in rat: Efficacy and distant bystander effect

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3529-3532

  Wei, Ming X ^a,b   Bougnoux, Philippe ^c   Sacré Salem, Béatrice ^d   Peyrat, Marie Bénédicte ^a   Lhuillery, Claude ^e   Salzmann, Jean Loup ^f   Klatzmann, David ^a,g  

^a SORBONNE UNIVERSITÉ   (France)

^b Génopoïétic   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d PFIZER INC   (United States)

^e CEMAGREF   (France)

^f UNIVERSITÉ PARIS 13   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; METHYLNITROSOUREA; NUCLEOSIDE DERIVATIVE; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER SIZE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE THERAPY; HERPES SIMPLEX VIRUS 1; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR; SUICIDE GENE;

ANIMALS; ANTIMETABOLITES; CARCINOGENS; FEMALE; GANCICLOVIR; GENE THERAPY; HERPESVIRUS 1, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; NEOPLASMS, MULTIPLE PRIMARY; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE KINASE; TRANSFECTION;

EID: 0032529454     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Moolten, F. L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 1: 279-287, 1994.
2. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
3. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J. L., and Klatzmann, D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024-7028, 1993.
4. Furman, P. A., McGuirt, P. V., Keller, P. M., Fyfe, J. A., and Elion, G. B. Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology, 102: 420-430, 1980.
5. Fyfe, J. A., Keller, P. M., Furman, P. A., Miller, R. L., and Elion, G. B. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J. Biol. Chem., 253: 8721-8727, 1978.
6. Elion, G. The biochemistry and mechanism of action of acyclovir. J. Antimicrob. Chemother., 12 (Suppl. B): 9-17, 1983.
7. Moolten, F. Tumor sensitivity conferred by inserted herpes thymidine kinase genes: paradigm for prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
8. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
9. Kianmanesh, A. R., Perrin, H., Panis, Y., Fabre, M., Nagy, H. J., Houssin, D., and Klatzmann, D. A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum. Gene Ther., 8: 1807-1814, 1997.
10. Freeman, S. M., Ramesh, R., and Marrogi, A. J. Immune system in suicide-gene therapy. Lancet, 349: 2-3, 1997.
11. Gagandeep, S., Brew, R., Green, B., Christmas, S. E., Klatzmann, D., Poston, G. J., and Kinsella, A. R. Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect." Cancer Gene Ther., 3: 83-88, 1996.
12. Vile, R. G., Nelson, J. A., Castleden, S., Chong, H., and Hart, I. R. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res., 54: 6228-6234, 1994.
13. Anonymous. Human gene marker/therapy clinical protocols. Hum. Gene Ther., 8: 629-658, 1997.
14. Gullino, P. M., Pettigrew, H. M., and Grantham, F. H. N-Nitrosomethylurea as mammary gland carcinogen in rats. J. Natl. Cancer Inst. (Bethesda), 54: 401-414, 1975.
15. Lhuillery, C., Bougnoux, P., Groscolas, R., and Durand, G. Time-course study of adipose tissue fatty acid composition during mammary tumor growth in rats with controlled fat intake. Nutr. Cancer, 24: 299-309, 1995.
16. Russo, J., Gusterson, B. A., Rogers, A. E., Russo, I. H., Wellings, S. R., and van Zwieten, M. J. Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62: 244-278, 1990.
17. Moon, R. C. Experimental breast cancer studies: paradigms for human breast cancer. In: F. Calvo, M. Crépin, and H. Magdalenat (eds.), Breast Cancer, Advances in Biology and Therapeutics, pp. 19-22. Paris: John Libbey Eurotext, 1996.
18. Sacco, M. G., Benedetti, S., Duflot-Dancer, A., Mesnil, M., Bagnasco, L., Strina, D., Fasolo, V., Villa, A., Macchi, P., Faranda, S., Vezzoni, P., and Finocchiaro, G. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer "in vivo." Gene Ther., 3: 1151-1156, 1996.
19. Dilber, M. S., and Smith, C. I. Suicide genes and bystander killing: local and distant effects. Gene Ther., 4: 273-274, 1997.